5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 5.80▲ | 6.09▼ |
MA10 | N/A | N/A | N/A | 5.83▲ | 6.12▼ |
MA20 | N/A | N/A | N/A | 6.06▼ | 5.61▲ |
MA50 | N/A | N/A | N/A | 6.01▼ | 5.72▲ |
MA100 | N/A | N/A | N/A | 5.59▲ | 5.37▲ |
MA200 | N/A | N/A | N/A | 5.78▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.038▼ | 0.038▲ |
RSI | N/A | N/A | N/A | 46.422▼ | 50.786▲ |
STOCH | N/A | N/A | N/A | 39.958 | 54.947 |
WILL %R | N/A | N/A | N/A | -56.538 | -41.551 |
CCI | N/A | N/A | N/A | -27.220 | 5.800 |
Tuesday, March 04, 2025 08:12 AM
As of March 4, 2025, the average one-year price target for Abeona Therapeutics is 16.12 GBX/share. The forecasts range from a low of 9.54 GBX to a high of 21.92 GBX. The average price target ...
|
Tuesday, March 04, 2025 08:12 AM
Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (LSE:0H7R) with a Outperform recommendation.
|
Wednesday, February 19, 2025 09:22 AM
Find the latest Abeona Therapeutics Inc. (0H7R.L) stock quote, history, news and other vital information to help you with your stock trading and investing.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 5.835 | 5.9089 | 5.835 | 5.839 | 2,605 |
02/07/25 | 5.80 | 6.03 | 5.56 | 5.98 | 7,170 |
01/07/25 | 5.89 | 5.89 | 5.50 | 5.655 | 3,836 |
30/06/25 | 5.79 | 5.79 | 5.655 | 5.7188 | 2,851 |
27/06/25 | 5.8521 | 5.8688 | 5.8088 | 5.8088 | 4,143 |
26/06/25 | 6.00 | 6.0088 | 5.8712 | 5.8888 | 942 |
25/06/25 | 5.84 | 5.895 | 5.69 | 5.895 | 2,839 |
24/06/25 | 5.84 | 5.8721 | 5.798 | 5.8721 | 1,667 |
23/06/25 | 6.00 | 6.00 | 5.755 | 5.819 | 7,126 |
20/06/25 | 6.03 | 6.03 | 5.7821 | 5.835 | 3,976 |
|
|
||||
|
|
||||
|
|